1 | Abatacept, rituximab or tocilizumab (Synonym: RUXIENCE) | 3件: Abatacept Abatacept, Rituximab (Synonym: Ruxience), Tocilizumab | 3件: D02596
D02596
,
D02994
(Name: RUXIENCE),
D03203
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 |
2 | ABP 798 - Biosimilar to rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
3 | ABP 798 Biosimilar to Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
4 | Administration of rituximab and methylprednisolone (Synonym: RUXIENCE) | 2件: Methylprednisolone Methylprednisolone, Rituximab (Synonym: Ruxience) | 2件: D00407
D00407
,
D02994
(Name: RUXIENCE) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
5 | Alemtuzumab and Rituximab (Synonym: RUXIENCE) | 2件: Alemtuzumab Alemtuzumab, Rituximab (Synonym: Ruxience) | 2件: D02802
D02802
,
D02994
(Name: RUXIENCE) | 2件: CD52 CD52, MS4A1 💬 | - | 1件: 60 60 |
6 | Alemtuzumab, Rituximab (Synonym: RUXIENCE) | 2件: Alemtuzumab Alemtuzumab, Rituximab (Synonym: Ruxience) | 2件: D02802
D02802
,
D02994
(Name: RUXIENCE) | 2件: CD52 CD52, MS4A1 💬 | 2件: , Hematopoietic cell lineage 💬 | 1件: 63 63 |
7 | Belimumab in SLE patients / Rituximab in RA patients (Synonym: RUXIENCE) | 2件: Belimumab Belimumab, Rituximab (Synonym: Ruxience) | 2件: D02994
D02994
(Name: RUXIENCE),
D03068
| 2件: MS4A1 MS4A1, TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 |
8 | Bendamustine, Rituximab (Synonym: RUXIENCE) | 2件: Bendamustine Bendamustine, Rituximab (Synonym: Ruxience) | 2件: D02994
D02994
(Name: RUXIENCE),
D07501
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
9 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine (Synonym: RUXIENCE) | 3件: Azathioprine Azathioprine, Dexamethasone, Rituximab (Synonym: Ruxience) | 3件: D00238
D00238
,
D00292
,
D02994
(Name: RUXIENCE) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
10 | Combination of Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
11 | Combination of Rituximab with subcutaneous belimumab (Synonym: RUXIENCE) | 2件: Belimumab Belimumab, Rituximab (Synonym: Ruxience) | 2件: D02994
D02994
(Name: RUXIENCE),
D03068
| 2件: MS4A1 MS4A1, TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 63 63 |
12 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |
13 | Cyclophosphamide/Rituximab (Synonym: RUXIENCE) | 2件: Cyclophosphamide Cyclophosphamide, Rituximab (Synonym: Ruxience) | 3件: D00287
D00287
,
D02994
(Name: RUXIENCE),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
14 | Dexamethasone and Rituximab (Synonym: RUXIENCE) | 2件: Dexamethasone Dexamethasone, Rituximab (Synonym: Ruxience) | 2件: D00292
D00292
,
D02994
(Name: RUXIENCE) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
15 | Double-Blind Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 51 51 |
16 | Dr. Reddy’s Rituximab (DRL_RI) 100mg (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
17 | Dr. Reddy’s Rituximab (DRL_RI) 500mg (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
18 | Eltrombopag combining rituximab (Synonym: RUXIENCE) | 2件: Eltrombopag Eltrombopag, Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
19 | Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab (Synonym: RUXIENCE) | 4件: Abatacept Abatacept, Rituximab (Synonym: Ruxience), Sarilumab, Tocilizumab | 4件: D02596
D02596
,
D02994
(Name: RUXIENCE),
D03203
,
D10161
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 |
20 | Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
21 | GP2013 - A Proposed biosimilar rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
22 | IDEC-C2B8 (rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
23 | Immunosuppressive treatment (eg, rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 64 64 |
24 | Individualized dose of rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
25 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (Synonym: RUXIENCE) | 12件: Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab (Synonym: Ruxience), Teriflunomide | 10件: D01370
D01370
,
D02802
,
D02994
(Name: RUXIENCE),
D03846
,
D05218
,
D06886
,
D09314
,
D10001
,
D10172
,
D11215
| 7件: CD52 CD52, DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 | - | 1件: 13 13 |
26 | Intravenous Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 66 66 |
27 | MabionCD20 (candidate biosimilar to rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
28 | MabThera (Rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 13 13, 46, 49, 53 |
29 | Mabthera or biosimilar Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
30 | Mabthera or biosimilar rituximab product (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
31 | MabThera® (rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
32 | Originator rituximab - Rituxan ® or MabThera ® (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
33 | Perfusion of treatment Rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
34 | Prednisone, low dose rituximab (Synonym: RUXIENCE) | 2件: Prednisone Prednisone, Rituximab (Synonym: Ruxience) | 2件: D00473
D00473
,
D02994
(Name: RUXIENCE) | 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
35 | RhTPO in combination with Rituximab (Synonym: RUXIENCE) | 2件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 |
36 | Rituxan (INN: Rituximab), brand name in the United States (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
37 | Rituxan (INN: Rituximab), brand name in the US (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
38 | Rituxan (rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
39 | Rituxan® (rituximab) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
40 | RITUXIMAB (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
41 | Rituximab (anti-CD20) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 |
42 | Rituximab (Arm A) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 |
43 | Rituximab (Arm B) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 |
44 | Rituximab (EU) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
45 | Rituximab (genetical recombination) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 14 14 |
46 | Rituximab (MABTHERA® or RITUXAN®). (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 35 35, 61 |
47 | Rituximab (Mabthera®) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
48 | Rituximab (Rituxan) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 11 11 |
49 | Rituximab (RTX) and Azathioprine (AZA) (Synonym: RUXIENCE) | 2件: Azathioprine Azathioprine, Rituximab (Synonym: Ruxience) | 2件: D00238
D00238
,
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 65 65 |
50 | Rituximab (US) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
51 | Rituximab - MabThera (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
52 | Rituximab 1g IV (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 162 162 |
53 | Rituximab [MabThera/Rituxan] (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 63 |
54 | Rituximab [MabThera] (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
55 | Rituximab and Cyclophosphamide IV (Synonym: RUXIENCE) | 2件: Cyclophosphamide Cyclophosphamide, Rituximab (Synonym: Ruxience) | 3件: D00287
D00287
,
D02994
(Name: RUXIENCE),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 35 35 |
56 | Rituximab and Hyaluronidase Human (Synonym: RUXIENCE) | 2件: Hyaluronidase Hyaluronidase, Rituximab (Synonym: Ruxience) | 4件: D02994
D02994
(Name: RUXIENCE),
D04455
,
D04456
,
D06604
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 331 331 |
57 | Rituximab combined with Omalizumab (Synonym: RUXIENCE) | 2件: Omalizumab Omalizumab, Rituximab (Synonym: Ruxience) | 2件: D02994
D02994
(Name: RUXIENCE),
D05251
| 2件: FCER1A FCER1A, MS4A1 💬 | 5件: Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 162 162 |
58 | Rituximab combined with tacrolimus induction + rituximab maintenance (Synonym: RUXIENCE) | 2件: Rituximab Rituximab (Synonym: Ruxience), Tacrolimus | 3件: D00107
D00107
,
D02994
(Name: RUXIENCE),
D08556
| 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
59 | Rituximab combined with tacrolimus induction + tacrolimus maintenance (Synonym: RUXIENCE) | 2件: Rituximab Rituximab (Synonym: Ruxience), Tacrolimus | 3件: D00107
D00107
,
D02994
(Name: RUXIENCE),
D08556
| 6件: MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
60 | Rituximab Infusion (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 222 |
61 | Rituximab IT (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
62 | Rituximab IV (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
63 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
64 | Rituximab MabThera (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
65 | Rituximab, Cyclophosphamide, and Corticosteroids (Synonym: RUXIENCE) | 2件: Cyclophosphamide Cyclophosphamide, Rituximab (Synonym: Ruxience) | 3件: D00287
D00287
,
D02994
(Name: RUXIENCE),
D07760
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
66 | Rituximab, Mabthera (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 |
67 | Rituximab, MTX, folic acid (Synonym: RUXIENCE) | 2件: Folic acid Folic acid, Rituximab (Synonym: Ruxience) | 2件: D00070
D00070
,
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
68 | Rituximab, observational study amon patients with active RA (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
69 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
70 | Rituximab-Pfizer (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
71 | Rituximab-Pfizer (PF-05280586) x 3 courses (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
72 | Rituximab-US + Rituximab-Pfizer x 2 Courses (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
73 | Rituximab/ Mabthera (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 271 271 |
74 | Ruxience | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
75 | SAIT101 (proposed rituximab biosimilar) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
76 | SAIT101 (rituximab biosimilar) (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
77 | Standard dose of rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 |
78 | The Standard Steroid Treatment, Plasma Exchange and rituximab (Synonym: RUXIENCE) | 1件: Rituximab Rituximab (Synonym: Ruxience) | 1件: D02994
D02994
(Name: RUXIENCE) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |